Focus on Public Health Policy
About This Show
Health policy matters stand to make impacts nationally and globally, from health insurance mandates to antibiotic stewardship protocols to drug and device clearances and recalls. ReachMD assembles key decision makers, policy experts and healthcare analysts for discussions of vital issues in healthcare policy.
Most Recent Episode
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s infection-fighting immune system. This can cause severe inflammation throughout the body and lead to hospitalization and death, especially if the reaction is not diagnosed and treated quickly. A link to the full communication detailing specific information for health care professionals and a list of FDA approved GBCAs can be found at www.fda.gov/Drugs/DrugSafety Released 4/25/2018